Health status of White Americans

HealthMetrix Research Selects 2023 Medicare Advantage Plans for Exceptional Benefit Value & Overall Performance

Retrieved on: 
Saturday, October 15, 2022
Health status of White Americans, City, Centers for Medicare & Medicaid Services, CMS, Center, Medicare, Excellent, Research, Health insurance

The 2023 Senior Choice Gold Award recipients were selected from Medicare Advantage plans across all states and Puerto Rico based on cost-sharing analysis conducted by HealthMetrix Research Inc. and posted on MedicareNewsWatch.com.

Key Points: 
  • The 2023 Senior Choice Gold Award recipients were selected from Medicare Advantage plans across all states and Puerto Rico based on cost-sharing analysis conducted by HealthMetrix Research Inc. and posted on MedicareNewsWatch.com.
  • The 2023 Senior Choice Gold Award selections include recognition for plans achieving at least 3.5-star overall ratings for quality and performance as reported by the Centers for Medicare & Medicaid Services (CMS).
  • HealthMetrix Research appreciates those informed Medicare beneficiaries who rely annually on this independent recognition when considering their Medicare Advantage+Part D options."
  • HealthMetrix Research neither recommends nor endorses specific Medicare Advantage plans.

EQS-News: New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope

Retrieved on: 
Monday, October 10, 2022
People, Quality of life, News, Muscle, Merck, Communication, Disease, Health status of White Americans, Therapy, Spinal cord, Amyotrophic lateral sclerosis, MS, Multiple sclerosis, Nerve Damage, Animal, Employment, NYSE, NASDAQ, Lists of diseases, Antibody, Cerev Del, Patient, Psychopharmacology, Research, NIH, Walking, HIV disease progression rates, ALS, Partnership, Motor neuron, Technology, Center, Immune system, SOD1, Disorder, Ketamine, Immune tolerance, National, Amyotrophy, Motor neuron disease, CNM, Advertising, CNS, Survival, Korea Disease Control and Prevention Agency, KTTA, Brain, Atrophy, Death, MRK, COVID-19, Psychiatry, Central nervous system, Neutralizing antibody, Pharmaceutical industry, Vaccine

People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later.

Key Points: 
  • People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later.
  • MS is a potentially disabling disease affecting the brain and spinal cord the bodys central nervous system.
  • The immune system of those with MS attacks the myelin, the protective sheath covering a persons nerve fibers.
  • Signs and symptoms of MS vary widely and depend on the amount of nerve damage and which nerves are affected.

New VISION Registry Report Summarizes Key Ocular Melanoma Patient-Reported Data to Advance Clinical Research and Treatments

Retrieved on: 
Monday, October 3, 2022
Massachusetts General Hospital, CURE, Facebook, Melanoma, Health status of White Americans, Hospital, Australian Melanoma Research Foundation, Physician, Research, OM, Industry, Disease, Health, Twitter, Investor, Uveal melanoma, Patient, Education, Goal, Caregiver, Biopsy, Eye, Quality of life, Communication, MRF, Leadership, ISOO, Acral lentiginous melanoma, HRQOL, Diagnosis, MD Anderson Cancer Center, Development and Educational Communication Unit, FACS, Organization, Awareness, Medicine, Telescopic sight, MD, Ophthalmology

WASHINGTON, Oct. 3, 2022 /PRNewswire-PRWeb/ -- Today, the Melanoma Research Foundation's (MRF) CURE OM initiative, dedicated to increasing awareness, education, support and research funding for ocular melanoma (OM) released its first-ever data report highlighting its Virtual Information System to Improve Outcomes and Networks (VISION) Registry's inaugural year. Launched in May 2021, VISION tracks patients from the time of diagnosis through their full experience with ocular melanoma. Patients from around the world can share their experiences with this rare disease to help advance patient care, quality of life and ultimately find a cure for OM. VISION collects patient-reported outcomes such as symptoms, health-related quality of life (HRQOL), perceived health status, experience with the health system and preferences to inform stakeholders on the patient experience. Understanding this holistic experience is pivotal to identify potential causes, improve quality of patient care and enhance clinical research resulting in better therapeutic interventions.

Key Points: 
  • Launched in May 2021, VISION tracks patients from the time of diagnosis through their full experience with ocular melanoma.
  • The VISION Registry Data Report provides key takeaways and accomplishments from the registry's first year and establishes a strong and impressive framework for future patient-centered resources, collaboration and research.
  • The report offers insight into areas such as socio-demographics, clinical care, patient experience, patient preferences and quality of life.
  • To view additional patient reported data and read OM community testimonials, you can access the 2022 VISION Registry Data Report here: melanoma.org/VisionDataReport .

The Worldwide Smart Pulse Oximeters Industry is Expected to Reach $3.4 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Medical Devices, Health, Porter's five forces analysis, Arrhythmia, Oxygen, Health status of White Americans, Philips, FDA, Prevalence, Acquisition, Growth, Emergency, Partnership, Hypertension, Industry, Diabetes, Oxygen saturation (medicine), Patient, World, World Health Organization, Benchmarking, Respiration, Heart rate, Diagnosis, US, Death, COPD, Hospital, Awareness, Asthma, Skin, Pulse oximetry, Sleep apnea, Ventricular septal defect, Hypoxemia, CAGR, Medical device, Medical imaging

The smart pulse oximeters market was valued at $1,639.19 million in 2021 and is expected to reach $3,453.29 million by 2031, growing at a CAGR of 7.7% from 2022 to 2031.

Key Points: 
  • The smart pulse oximeters market was valued at $1,639.19 million in 2021 and is expected to reach $3,453.29 million by 2031, growing at a CAGR of 7.7% from 2022 to 2031.
  • Smart pulse oximeters are used during emergencies, pre-and post-surgery, on-going treatment at hospitals, and home healthcare.
  • In addition, upsurge in geriatric population and rise in chronic health conditions including COPD, and sleep apnea, have fueled the growth of smart pulse oximeters market.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart pulse oximeters market analysis from 2021 to 2031 to identify the prevailing smart pulse oximeters market opportunities.

The Worldwide Pulse Oximeters Industry is Expected to Reach $3.9 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Medical Devices, Health, World, Porter's five forces analysis, Arrhythmia, Health status of White Americans, Texas Homecare, Prevalence, Blood, World Health Organization, Acquisition, Growth, Emergency, Partnership, Hypertension, Industry, Diabetes, Patient, Benchmarking, COP, Heart rate, Diagnosis, Death, COPD, Hospital, Awareness, Asthma, Chronic obstructive pulmonary disease, Sleep-related breathing disorder, Medical device, Health insurance, Medical imaging

In addition, surge in geriatric population and rise in chronic health conditions including COP and sleep apnea, have fueled the growth of pulse oximeters market.

Key Points: 
  • In addition, surge in geriatric population and rise in chronic health conditions including COP and sleep apnea, have fueled the growth of pulse oximeters market.
  • In addition, increase in prevalence of diseases such as hypertension, asthma, diabetes, and cardiac arrhythmia has significantly uplifted the demand for pulse oximeters.
  • Fingertip pulse oximeters are one such portable oximeters used in all healthcare settings including homecare, clinical settings, and hospitals.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulse oximeters market analysis from 2021 to 2031 to identify the prevailing pulse oximeters market opportunities.

CATL to Highlight Advancements in Energy Storage Solutions at RE+ 2022

Retrieved on: 
Wednesday, September 21, 2022
WEF, Probability, Carbon, Temperature, Safety, CTP, CATL, Health status of White Americans, Ningde, Climate change, GLN, BESS, Cost of electricity by source, Cell, Solution, Life expectancy, World Economic Forum, BMS, Research, Solar Power International, Renewable energy, Electric battery, Limited

ANAHEIM, Calif., Sept. 21, 2022 /PRNewswire/ -- Contemporary Amperex Technology Co., Limited (CATL), a global leader of new energy innovative technologies, presents its state-of-the-art all-scenario energy storage solutions at Solar Power International as part of RE+ 2022, held in Anaheim, CA from September 20-22. The conference is the largest and most comprehensive clean energy industry event in North America.

Key Points: 
  • Key technological innovations enabling highly reliable, safe energy storage solutions across power generation, power transmission and distribution, power consumption to empower energy freedom for all
    ANAHEIM, Calif., Sept. 21, 2022 /PRNewswire/ -- Contemporary Amperex Technology Co., Limited (CATL), a global leader of new energy innovative technologies, presents its state-of-the-art all-scenario energy storage solutions at Solar Power International as part of RE+ 2022 , held in Anaheim, CA from September 20-22.
  • Energy storage solutions play a vital role in enabling the shift and innovation is key to unlocking the full potential of renewable energy by reducing energy storage system cost, increasing service life, durability, energy density, and safety.
  • Committed to providing first-class energy storage solutions, CATL has developed lithium-ion battery energy storage systems across application scenarios in power generation, power transmission and distribution, and power consumption.
  • In 2021, CATL's energy storage business ranked first in its market share of global energy storage battery production, supporting over 100 utility-scale projects around the world.

CATL to Highlight Advancements in Energy Storage Solutions at RE+ 2022

Retrieved on: 
Wednesday, September 21, 2022
WEF, Probability, Carbon, Temperature, Safety, CTP, CATL, Health status of White Americans, Ningde, Climate change, GLN, BESS, Cost of electricity by source, Cell, Solution, Life expectancy, World Economic Forum, BMS, Research, Multimedia, Solar Power International, Renewable energy, Electric battery, Limited

ANAHEIM, Calif., Sept. 21, 2022 /PRNewswire/ -- Contemporary Amperex Technology Co., Limited (CATL), a global leader of new energy innovative technologies, presents its state-of-the-art all-scenario energy storage solutions at Solar Power International as part of RE+ 2022, held in Anaheim, CA from September 20-22. The conference is the largest and most comprehensive clean energy industry event in North America.

Key Points: 
  • Key technological innovations enabling highly reliable, safe energy storage solutions across power generation, power transmission and distribution, power consumption to empower energy freedom for all
    ANAHEIM, Calif., Sept. 21, 2022 /PRNewswire/ -- Contemporary Amperex Technology Co., Limited (CATL), a global leader of new energy innovative technologies, presents its state-of-the-art all-scenario energy storage solutions at Solar Power International as part of RE+ 2022 , held in Anaheim, CA from September 20-22.
  • Energy storage solutions play a vital role in enabling the shift and innovation is key to unlocking the full potential of renewable energy by reducing energy storage system cost, increasing service life, durability, energy density, and safety.
  • Committed to providing first-class energy storage solutions, CATL has developed lithium-ion battery energy storage systems across application scenarios in power generation, power transmission and distribution, and power consumption.
  • In 2021, CATL's energy storage business ranked first in its market share of global energy storage battery production, supporting over 100 utility-scale projects around the world.

Humana Introduces Mid-Term Adjusted EPS Target of $37 in 2025 and Raises Full Year 2022 Adjusted EPS Financial Guidance to ‘approximately $25’ at Investor Day

Retrieved on: 
Thursday, September 15, 2022
General Health, Health, Professional Services, Insurance, Health Insurance, Star, Adoption, COVID-19 vaccine, Health, Movement, Medicare, GAAP, Health status of White Americans, Risk, Sale, MA, Privacy, CMS, Population, Compliance, Growth, News, Judgement, Private Securities Litigation Reform Act, Information technology, Family, Government, Investment, Phrase, U.S. Securities and Exchange Commission, Medicare Advantage, Vaccine, Home, Investor relations, Hospice, Coronavirus, EPS, Information, Form, Security (finance), Pharmacy, COVID-19 testing, SEC, Marketing, Mortality, Personal care, Failure, Lifting, Industry, Pharmaceutical industry, Bank, Renewable energy, Risk management, Life insurance, Cryptocurrency, Public relations, Insurance, Health insurance, Financial adviser, COVID-19, Humana

The Investor Day webcast and virtual presentation may be accessed via Humanas Investor Relations page at https://humana.gcs-web.com/ .

Key Points: 
  • The Investor Day webcast and virtual presentation may be accessed via Humanas Investor Relations page at https://humana.gcs-web.com/ .
  • (a) FY 2022 projected Adjusted results exclude the following:
    Amortization expense for identifiable intangibles of approximately $0.43 per diluted common share.
  • Put/call valuation adjustments of approximately $0.18 per diluted common share, associated with Humanas non-consolidating minority interest investments as of June 30, 2022.
  • FY 2022 GAAP EPS guidance excludes the impact of future value changes of these put/call options as the future value changes cannot be estimated.

Redwood Living, Inc. announces 2022 contributions to nonprofits championed by residents, employees, investors

Retrieved on: 
Wednesday, August 31, 2022
University, Research, Blog, Education, Organization, Human, Health status of White Americans, Social media, Woman, Growth, Running, Mail order, Public relations, Sequoioideae

Additionally, because so many worthy causes were lifted up by Redwood Ambassadors, Redwood is planning to find additional ways to support them in the coming year.

Key Points: 
  • Additionally, because so many worthy causes were lifted up by Redwood Ambassadors, Redwood is planning to find additional ways to support them in the coming year.
  • Redwood Cares is one of multiple ways Redwood embraces giving back.
  • Redwood Living, Inc. (Redwood) is an innovative development and property management company with neighborhoods in Ohio, Michigan, Indiana, Illinois, Iowa, North Carolina, South Carolina, and Kentucky, currently.
  • The company will begin construction in Nebraska during 2022, with potential projects planned for markets in Missouri after that.

BION Is Now Available for Trading on LBank Exchange

Retrieved on: 
Saturday, August 27, 2022
BION, Collection, Roger Hawkins (drummer), Government, Insurance, Solution, Sale, AML, Policy, Hospital, Genome, FDS, Association, Health status of White Americans, Reward, Social, Risk, Marketing, Adoption, Cryptocurrency, Risk management

Internet City, Dubai--(Newsfile Corp. - August 27, 2022) - LBank Exchange, a global digital asset trading platform, has listed BION on August 26, 2022.

Key Points: 
  • Internet City, Dubai--(Newsfile Corp. - August 27, 2022) - LBank Exchange, a global digital asset trading platform, has listed BION on August 26, 2022.
  • For all users of LBank Exchange, the BION/USDT trading pair is now officially available for trading.
  • Its native token BION has been listed on LBank Exchange at 16:00 (UTC+8) on August 26, 2022, to further expand its global reach and help it achieve its vision.
  • The BION token has been listed on LBank Exchange at 16:00 (UTC+8) on August 26, 2022, investors who are interested in the BION investment can easily buy and sell BION token on LBank Exchange right now.